Inhibition of EP300/CREBBP bromodomains mediates antiproliferative responses in AML and CML cell lines by interfering with transcription of oncogenes such as MYC [115] and inducing G0/G1 arrest [25]. This evidence concerns the gene MYC and acute myeloid leukemia.